Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
EMC2 - Antiretroviral therapy effect on brain of patients with HIV-associated neurocognitive disorders
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
ENDOD1 - Antiretroviral therapy effect on brain of patients with HIV-associated neurocognitive disorders
TF - Antiretroviral therapy effect on brain of patients with HIV-associated neurocognitive disorders
SEP15 - Antiretroviral therapy effect on brain of patients with HIV-associated neurocognitive disorders
ELOVL5 - Antiretroviral therapy effect on brain of patients with HIV-associated neurocognitive disorders
UNC50 - Antiretroviral therapy effect on brain of patients with HIV-associated neurocognitive disorders
MOG - Antiretroviral therapy effect on brain of patients with HIV-associated neurocognitive disorders
HNRNPA2B1 - Antiretroviral therapy effect on brain of patients with HIV-associated neurocognitive disorders
CLASP2 - Antiretroviral therapy effect on brain of patients with HIV-associated neurocognitive disorders
SEL1L2 - Antiretroviral therapy effect on brain of patients with HIV-associated neurocognitive disorders
MAN2A2 - Antiretroviral therapy effect on brain of patients with HIV-associated neurocognitive disorders
ATP11A - Antiretroviral therapy effect on brain of patients with HIV-associated neurocognitive disorders
CDKN1B - Antiretroviral therapy effect on brain of patients with HIV-associated neurocognitive disorders
SLC44A1 - Antiretroviral therapy effect on brain of patients with HIV-associated neurocognitive disorders
PTK2 - Antiretroviral therapy effect on brain of patients with HIV-associated neurocognitive disorders
ARPC5 - Antiretroviral therapy effect on brain of patients with HIV-associated neurocognitive disorders
ENPP2 - Antiretroviral therapy effect on brain of patients with HIV-associated neurocognitive disorders
GCLC - Antiretroviral therapy effect on brain of patients with HIV-associated neurocognitive disorders
CTTNBP2 - Antiretroviral therapy effect on brain of patients with HIV-associated neurocognitive disorders
CCDC47 - Antiretroviral therapy effect on brain of patients with HIV-associated neurocognitive disorders
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on